Capital Returns and Share Repurchases - Enact Holdings provided $76 million of capital returns to Genworth Holdings in Q1 2025, contributing to strategic initiatives and share repurchases[292] - Genworth Financial has repurchased $600 million worth of shares since the initiation of its share repurchase program in May 2022[292] - Genworth Holdings received $76 million in capital returns from Enact Holdings during the first quarter of 2025, including $53 million from share repurchases and $23 million from dividends[343] - Enact Holdings announced a new share repurchase program allowing for the repurchase of up to $350 million of its common stock[452] - Genworth Financial repurchased 6,516,857 shares at an average price of $6.91 per share for a total of $45 million during the three months ended March 31, 2025[453] Long-Term Care Insurance Performance - The long-term care insurance multi-year in-force rate action plan has achieved an estimated cumulative economic benefit of approximately $31.3 billion since 2012[293] - CareScout Services increased its network of long-term care providers to 543, a 10% increase from December 31, 2024, and had 576 matches in Q1 2025, a 34% increase from Q4 2024[295] - Genworth plans to invest approximately $45 million to $50 million in CareScout Services for the full year 2025 to enhance its offerings[295] - The individual long-term care insurance product, CareScout Care Assurance, was approved for 23 jurisdictions and is set to launch later in 2025[296] - Genworth plans to contribute $75 million of capital to its CareScout Insurance subsidiary for regulatory capital requirements in 2025[296] - The Long-Term Care Insurance segment reported an adjusted operating loss of $30 million in Q1 2025 compared to a profit of $3 million in Q1 2024[317] - Total revenues for the Long-Term Care Insurance segment decreased by 5% to $1.051 billion for the three months ended March 31, 2025, compared to $1.105 billion in the same period in 2024[384] - Premiums in the Long-Term Care Insurance segment decreased by 1% to $571 million, primarily due to lower renewal premiums and policy terminations[384] - The company expects overall claims costs in the Long-Term Care Insurance segment to continue increasing as the average attained ages of insured individuals rise[376] - The company has observed an increase in the cost of care in the Long-Term Care Insurance business, which could adversely impact liquidity and financial condition if the trend persists[378] - The company is pursuing premium rate increases and associated benefit reductions on in-force policies to improve the risk and profitability profile of the Long-Term Care Insurance business[381] - Legal settlements regarding premium increases have covered approximately 70% of the long-term care insurance block, resulting in a net favorable economic impact by reducing tail risk[382] - The long-term care insurance business expects overall claim costs to continue increasing over time as the blocks age, with peak claim years over a decade away[460] - Renewal premiums on the in-force block of the legacy long-term care insurance business are expected to decline over time, partially offset by future approved rate actions[461] Financial Performance Overview - Total revenues decreased by 4% from $1,864 million in Q1 2024 to $1,786 million in Q1 2025[305] - Net income available to common stockholders dropped by 61% from $139 million in Q1 2024 to $54 million in Q1 2025[305] - Adjusted operating income available to common stockholders decreased by 40% from $85 million in Q1 2024 to $51 million in Q1 2025[317] - Income from continuing operations fell by 47% from $170 million in Q1 2024 to $90 million in Q1 2025[305] - Basic earnings per share from continuing operations decreased by 56% from $0.32 in Q1 2024 to $0.14 in Q1 2025[316] - Net investment income declined by 5% from $782 million in Q1 2024 to $739 million in Q1 2025[305] - Policy fees and other income remained stable at $158 million for both Q1 2024 and Q1 2025[305] - Benefits and other changes in policy reserves increased by 1% from $1,203 million in Q1 2024 to $1,217 million in Q1 2025[305] - Interest expense decreased by 13% from $30 million in Q1 2024 to $26 million in Q1 2025[305] - Net income for the first quarter of 2025 was $54 million, down from $139 million in the same period of 2024, with adjusted operating income decreasing from $85 million to $51 million[322] Investment and Capital Management - The investment portfolio as of March 31, 2025, totaled $60.585 billion, an increase from $59.976 billion as of December 31, 2024[434] - The fixed maturity securities portfolio was 97% investment grade, comprising 75% of total invested assets and cash[427] - As of March 31, 2025, the company posted initial margin of $81 million to clearing agents, which was $41 million more than required by the clearinghouse[427] - Net investment gains for the three months ended March 31, 2025, were $27 million, compared to $49 million in the same period of 2024[433] - The company recorded $18 million of lower net realized losses related to the sale of available-for-sale fixed maturity securities in the current year[433] - The carrying value of available-for-sale fixed maturity securities was $31.103 billion, representing 51% of total invested assets as of March 31, 2025[434] - Total assets increased by $385 million from $86,871 million as of December 31, 2024, to $87,256 million as of March 31, 2025[441] - Total liabilities increased by $135 million from $77,440 million as of December 31, 2024, to $77,575 million as of March 31, 2025[442] - Total equity increased by $250 million from $9,431 million as of December 31, 2024, to $9,681 million as of March 31, 2025[443] - Net cash from operating activities was $34 million for the three months ended March 31, 2025, compared to net cash used of $(107) million in the prior year[447] Ratings and Regulatory Actions - Fitch Ratings upgraded the financial strength rating of Enact Mortgage Insurance Corporation to "A" from "A-" with a stable outlook on January 17, 2025[298] - The consolidated risk-based capital ratio for U.S. life insurance subsidiaries was approximately 304% as of March 31, 2025, down from 306% at the end of 2024[324] - State filings approved for in-force rate actions were 19 in Q1 2025, down from 23 in Q1 2024, with impacted in-force premiums decreasing from $166 million to $85 million[396] - The weighted-average percentage rate increase approved rose to 28% in Q1 2025 from 25% in Q1 2024, while gross incremental premiums approved decreased from $41 million to $24 million[396] - The cumulative economic benefit of approved rate actions since 2012 through Q1 2025 was approximately $31.3 billion on a net present value basis[396] - The company continues to pursue significant premium rate increases and associated benefit reductions to maintain the self-sustainability of its legacy U.S. life insurance subsidiaries[393] Market and Economic Conditions - Employee costs have increased due to wage inflation and a competitive labor market, with potential material adverse impacts on liquidity if inflationary pressures persist[462] - Market risk remains unchanged since December 31, 2024, with no material changes in market conditions affecting interest rates[470] - The company has provided a guarantee for AXA's recovery of certain PPI mis-selling losses, with a potential payment obligation of up to £80 million[466] - There have been no material changes to guarantees or contractual obligations compared to the amounts disclosed in the 2024 Annual Report[467]

Financial Data and Key Metrics Changes - Genworth reported net income of $54 million or $0.13 per share for Q1 2025, with adjusted operating income of $51 million [9][24] - The liquidity position remains strong, ending the quarter with cash and liquid assets of $211 million [10][36] - The total estimated pretax statutory loss for U.S. Life insurance companies was $1 million, primarily driven by losses in life and annuities [9][32] Business Line Data and Key Metrics Changes - Enact contributed $137 million in adjusted operating income, reflecting strong performance and reserve releases [9][28] - The long-term care insurance segment reported an adjusted operating loss of $30 million, impacted by lower limited partnership income and anticipated premium declines [25] - Life and Annuities reported an adjusted operating loss of $33 million, with life insurance losses of $34 million due to seasonally high mortality [27][32] Market Data and Key Metrics Changes - CareScout achieved a significant increase in matches between policyholders and providers, growing from 52 matches in Q1 2024 to 576 in Q1 2025, representing over a 10x increase year over year [13] - The CareScout quality network now includes nearly 550 providers, achieving 90% coverage for the aged 65 census population in the U.S. [14][15] Company Strategy and Development Direction - The company continues to focus on three strategic priorities: increasing shareholder value, maintaining self-sustainability of legacy businesses, and expanding CareScout services [10][12] - Genworth is committed to managing U.S. life insurance companies as a closed system, leveraging existing reserves and capital to cover future claims without additional capital injections [31] - The company is developing a hybrid long-term care product and expanding its CareScout network to include assisted living communities [16][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating potential macroeconomic challenges, including tariff negotiations and possible recession scenarios, while emphasizing the growing demand for aging care products [20][21] - The company anticipates continued strong growth in CareScout and expects to return similar levels of capital to shareholders in 2025 as in 2024 [29][38] Other Important Information - The company is actively engaged with policymakers regarding the WISH Act, which aims to provide financial support for long-term care [17][66] - Genworth has agreed to cover up to £80 million of AXA's losses in ongoing litigation, aligning interests for maximum recovery [41][42] Q&A Session Summary Question: Clarification on AXA litigation agreement - Management clarified that the agreement with AXA ensures alignment of interests for maximum recovery, with AXA claiming damages of approximately $700 million [41][42] Question: Future capital contributions for CareScout - Management indicated that while significant upfront capital is required for the new insurance entity, future contributions are expected to be manageable, potentially in the range of $20 million to $25 million over time [44][48] Question: Breakeven timeline for CareScout quality network - Management noted that while CareScout is not yet at breakeven, the projected savings from the network could significantly impact Genworth's claim costs, adding value to the company [50][54] Question: Tailwinds from the WISH Act for CareScout - Management discussed how the WISH Act could provide a framework for catastrophic coverage, aligning well with CareScout's offerings and addressing the long-term care financing gap [58][66]

Financial Data and Key Metrics Changes - Genworth reported net income of $54 million or $0.13 per share for the first quarter of 2025, with adjusted operating income of $51 million [9][24] - The total estimated pretax statutory loss for U.S. Life insurance companies was $1 million, primarily driven by losses in life and annuities [10][31] - Liquidity remains strong with cash and liquid assets of $211 million at the end of the first quarter [11][34] Business Line Data and Key Metrics Changes - Enact contributed $137 million in adjusted operating income, reflecting strong performance and reserve releases [9][27] - The long-term care insurance segment reported an adjusted operating loss of $30 million, impacted by lower limited partnership income and anticipated premium declines [25] - Life and Annuities reported an adjusted operating loss of $33 million, with Life Insurance reflecting a loss of $44 million due to seasonally high mortality [26][31] Market Data and Key Metrics Changes - CareScout achieved a dramatic increase in matches between Genworth policyholders and quality network providers, rising to 576 from 52 year-over-year [14] - The CareScout quality network now includes nearly 550 providers, achieving 90% coverage for the aged 65 census population in the U.S. [15][16] Company Strategy and Development Direction - Genworth is focused on three strategic priorities: increasing shareholder value, maintaining self-sustainability of legacy businesses, and expanding CareScout services [11][12][13] - The company is actively engaging with policymakers regarding the WISH Act, which aims to provide financial support for long-term care [18][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating potential macroeconomic challenges, including a moderate recession, due to low holding company debt and strong liquidity [21][22] - The demand for aging care products is expected to rise significantly as the baby boomer population ages, regardless of economic conditions [22][23] Other Important Information - Genworth's share repurchase program has repurchased a total of $600 million worth of shares at an average price of $5.75 per share since its initial authorization [12] - The company is developing a hybrid long-term care product and has received product approval from 23 states [17] Q&A Session Summary Question: Clarification on AXA litigation agreement - Management clarified that the agreement with AXA involves covering up to £80 million of losses, aligning interests for maximum recovery [41][42][43] Question: Future capital contributions for CareScout - Management indicated that the initial capital contribution of $75 million is significant, but future contributions would be manageable, likely in the range of $20-25 million over time [44][46][48] Question: Breakeven timeline for CareScout quality network - Management noted that while breakeven may take time, the projected savings from the network could already add significant value to the company [49][50][53] Question: Tailwinds from the WISH Act for CareScout - Management discussed how the WISH Act could provide a framework for catastrophic coverage, aligning well with CareScout's offerings [57][62][63]

Earnings Summary April 30, 2025 1Q Investor Presentation 1 Cautionary Note Regarding Forward-Looking Statements This presentation contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as "expects," "intends," "anticipates," "plans," "believes," "seeks," "estimates," "will," "may" or words of similar meaning and include, but are not limited to, statements regarding the outlook for th ...

Financial Performance - Total revenues for Q1 2025 were $1,786 million, a slight increase from $1,864 million in Q1 2024[33] - Net income available to common stockholders for Q1 2025 was $54 million, compared to a loss of $1 million in Q4 2024 and $85 million in Q3 2024[36] - Adjusted operating income for Q1 2025 was $51 million, up from $15 million in Q4 2024 and $48 million in Q1 2024[36] - Basic earnings per share for continuing operations in Q1 2025 was $0.14, compared to $0.01 in Q4 2024 and $0.20 in Q3 2024[36] - Total revenues for the Long-Term Care Insurance Segment in Q1 2025 were $1,051 million, slightly down from $1,105 million in Q1 2024[59] - Adjusted Operating Loss for the Long-Term Care Insurance Segment was $30 million in Q1 2025, compared to a profit of $3 million in Q1 2024[59] - Total revenues for the Life and Annuities Segment in Q1 2025 were $421 million, a decrease from $461 million in Q1 2024[66] - Adjusted Operating Loss for the Life and Annuities Segment was $33 million in Q1 2025, compared to a loss of $1 million in Q1 2024[66] - The loss from continuing operations for Q1 2025 was $44 million, compared to a loss of $29 million in Q1 2024[69] - The total premiums for the first quarter of 2025 were $862 million, slightly down from $875 million in the first quarter of 2024[98] Assets and Liabilities - Total assets as of March 31, 2025, were $87,256 million, an increase from $86,871 million at the end of 2024[39] - Total liabilities as of March 31, 2025, amounted to $77,575 million, a slight increase from $77,440 million on December 31, 2024[42] - Policyholder account balances stood at $14,447 million as of March 31, 2025, a decrease from $14,594 million on December 31, 2024[42] - Future policy benefits liabilities were recorded at $54,158 million as of March 31, 2025, compared to $53,610 million at the end of 2024, indicating a rise of approximately 1.02%[42] - Total equity increased to $9,681 million as of March 31, 2025, compared to $9,431 million at the end of 2024, reflecting a growth of approximately 2.65%[42] Investment Income - The company reported net investment income of $739 million in Q1 2025, down from $782 million in Q1 2024[33] - U.S. GAAP Net Investment Income for Q1 2025 was $739 million, a decrease from $782 million in Q1 2024[86] - Net investment income for Q1 2025 was $144 million, consistent with Q4 2024, but down from $167 million in Q1 2024[69] - Policy loans generated a net investment income of $36 million in Q1 2025, down from $58 million in Q1 2024[86] - Limited partnerships contributed $8 million to net investment income in Q1 2025, a decrease from $20 million in Q1 2024[86] Insurance Operations - New insurance written for the Enact segment is regularly monitored as a measure of new business volume generated[22] - The company considers the loss ratio for the Enact segment as a measure of underwriting performance, which is calculated as benefits and other changes in policy reserves to net earned premiums[24] - Direct Primary New Insurance Written (NIW) for Q1 2025 was $9,818 million, a decrease from $10,526 million in Q1 2024[54] - Direct Primary Insurance In-Force remained stable at $268,366 million in Q1 2025 compared to $263,645 million in Q1 2024[54] - Primary Delinquencies increased to 22,349 in Q1 2025 from 19,492 in Q1 2024, indicating a rise in risk[54] - The Loss Ratio for Q1 2025 was 12%, up from a negative 7% in Q1 2024, reflecting increased claims relative to premiums[54] Equity and Shareholder Information - Total stockholders' equity as of March 31, 2025, is $8,710 million, an increase from $8,494 million as of December 31, 2024[28] - Book value per share increased to $20.94 as of March 31, 2025, compared to $20.16 as of December 31, 2024[28] - The weighted-average common shares used in basic earnings per share calculations for the first quarter of 2025 is 418.3 million[28] - The weighted-average common shares outstanding for Q1 2025 were 418.3 million, a decrease from 443.0 million in Q1 2024[36] Comprehensive Income - The company reported a total accumulated other comprehensive loss of $1,421 million as of March 31, 2025, down from $1,642 million as of December 31, 2024[28] - Total accumulated other comprehensive income (loss) improved to $(1,421) million as of March 31, 2025, from $(1,642) million on December 31, 2024[42] Investment Strategy - The company continues to focus on maintaining a balanced investment strategy while managing credit risk effectively[81] - The overall investment portfolio composition remains diversified, with fixed maturity securities making up a significant portion of the total assets[81] - Public fixed maturity securities accounted for 43% of the total investment portfolio, with a carrying amount of $26,470 million, slightly up from $26,159 million in the previous quarter[81] - Private fixed maturity securities remained stable at 18% of the total portfolio, with a carrying amount of $11,166 million, compared to $10,882 million in the previous quarter[81]

Group 1 - No relevant content found in the provided documents [1][2]

Housing Market and Mortgage Insurance - The U.S. housing market saw a significant decline in mortgage originations from 2022 to 2024, primarily due to rising interest rates, low housing supply, and affordability issues, leading to lower new insurance written at Enact Holdings [255]. - Rising interest rates could increase defaults, as borrowers may struggle to qualify for replacement loans, and could negatively affect home prices, increasing the risk of loss for Enact Holdings [255]. - A decline in home values could lead to higher frequency and severity of defaults, impacting the company's financial condition and results of operations [258]. - Changes to the charters or practices of GSEs could adversely affect the company's business and financial condition, particularly regarding mortgage insurance [284]. - The FHFA's Enterprise Capital Framework could lead to increased guarantee pricing by GSEs, negatively impacting the private mortgage insurance market [285]. - The company may not be eligible to write new insurance on loans acquired by GSEs if it fails to meet PMIERs requirements [292]. - Changes in regulations affecting the mortgage insurance markets could significantly reduce demand for the company's services [299]. - Enact Holdings' largest customer accounted for 20% of its total new insurance written and 11% of its total revenues in 2024 [312]. - The top five customers generated 34% of Enact Holdings' new insurance written in 2024 [312]. - Regulatory changes, such as the proposed Basel III Endgame rule, could decrease the demand for mortgage insurance if adopted as proposed [303]. - The Dodd-Frank Act requires originators to retain a specified percentage of credit risk on securitized mortgages, which could adversely affect future demand for mortgage insurance if definitions change unfavorably [302]. - A decrease in high loan-to-value mortgage originations could lead to a decline in Enact Holdings' revenue, as demand for mortgage insurance would be reduced [333]. - Alternatives to private mortgage insurance may reduce the amount of insurance written by Enact Holdings, adversely impacting revenue [338]. - Delegated underwriting programs represent approximately 70% of new insurance written, which could expose Enact Holdings to unanticipated claims if guidelines are not followed [341]. Regulatory Environment - The company is heavily reliant on obtaining significant premium rate increases and associated benefit reductions for the sustainability of its legacy U.S. life insurance subsidiaries [263]. - Regulatory approval is required for premium increases in long-term care insurance, which can be a lengthy process and may not always be granted [265]. - Future premium rate increases and associated benefit reductions may not be realized if regulatory approvals are not obtained, potentially leading to increased reserves and adverse impacts on earnings [266]. - The company is subject to extensive regulation, which may limit profitability and growth, and changes in regulation could have a material adverse effect on its business [268]. - An adverse change in the regulatory requirements on U.S. life insurance subsidiaries could materially impact the company's business and financial condition [281]. - The company faces challenges in its principal U.S. life insurance subsidiaries, particularly those relying heavily on in-force rate actions for earnings and capital [281]. - The RBC ratio of each of the company's U.S. life insurance subsidiaries exceeded the level that would require corrective action as of December 31, 2024 [281]. - The company may experience variability in statutory results and a decline in RBC ratios due to the time lag in realizing benefits from in-force rate actions [281]. - The company is subject to minimum statutory capital requirements, which if not met, could restrict its ability to conduct business [296]. - The NAIC adopted amendments to the MGI Model Act in August 2023, which could have a material adverse effect on the mortgage guaranty insurance market [297]. - Changes in federal and state regulations could materially affect the operations and profitability of Enact Holdings [301]. Operational Risks - Higher persistency on existing insured loans was observed, as prevailing market interest rates exceeded the mortgage interest rates of most of Enact Holdings' loan portfolio [255]. - The company faces potential adverse impacts on operations if the volume of new insurance written remains suppressed for an extended period [255]. - The company faces intense competition for qualified employees, which could adversely impact its operations and financial condition [309]. - Geographic concentration in the mortgage portfolio increases exposure to localized economic conditions, despite efforts to diversify [314]. - The effectiveness of disclosure controls and internal control over financial reporting may not prevent errors or misstatements, potentially impacting investor confidence [315]. - Enact Holdings relies on third-party vendors for efficient execution of processes, which may lead to reputational damage and financial impact if these vendors fail to meet obligations [325]. - Enact Holdings may face challenges in maintaining or increasing capital in its mortgage insurance subsidiaries, potentially affecting business performance and regulatory compliance [327]. - The ability to raise additional capital through stock issuance is limited, which could adversely impact Enact Holdings' business and financial condition [329]. - Reinsurance availability and affordability are impacted by financial performance and market conditions, potentially increasing risk and capital requirements for Enact Holdings [331]. Emerging Risks - Approximately 2.5 million to 2.7 million personal information records were exposed due to a cybersecurity incident involving a third-party vendor [320]. - Advances in medical technology and genetic research could affect the financial performance of Enact Holdings' life insurance and long-term care insurance businesses [343]. - Medical advances may lead to longer payment durations under life insurance policies, potentially reducing profitability [346]. - Slower medical advancements in cognitive decline could increase claims duration in long-term care insurance, impacting financial performance [346]. - Emerging risks include natural disasters, geopolitical tensions, and public health emergencies, which could adversely affect business operations and financial condition [348]. - Geopolitical tensions, such as the Russia-Ukraine conflict, may increase costs and disrupt supply chains, impacting overall economic environment [348]. - The company faces risks from potential public health emergencies similar to those experienced during COVID-19, affecting business operations [348]. - Inability to leverage new technology developments, particularly in artificial intelligence, could hinder future business success and increase compliance costs [349]. - Competitors may adopt artificial intelligence technologies more effectively, posing a competitive risk to the company [349]. - Poor implementation of new technologies could lead to additional risks that may adversely impact business and financial condition [349].

Core Viewpoint - Genworth Financial (NYSE: GNW) is undergoing a multi-year turnaround, presenting a strong investment opportunity as indicated by a "Strong Buy" rating [1] Company Summary - Genworth Financial is currently in the midst of a significant transformation aimed at improving its market position and financial performance [1] - The company is believed to be undervalued, with potential for profit due to its less widespread following among average investors [1] Analyst Position - The analyst holds a beneficial long position in Genworth Financial shares, indicating confidence in the company's future performance [2]

Financial Data and Key Metrics Changes - For Q4 2024, Genworth reported a net loss of $1 million, while adjusted operating income was $15 million, primarily driven by Enact's strong performance contributing $137 million to adjusted operating income [13][14] - For the full year, net income was $299 million or $0.68 per share, with adjusted operating income of $273 million [14][33] - The total estimated pretax statutory loss for U.S. life insurance companies was $33 million for Q4, while full-year statutory pretax income was $378 million, including a $355 million benefit from legal settlements [15][48] Business Line Data and Key Metrics Changes - The long-term care (LTC) insurance segment reported an adjusted operating loss of $104 million in Q4, driven by liability remeasurement losses and unfavorable assumption updates [30] - Enact's adjusted operating income for Q4 was $137 million, reflecting a 6% year-over-year increase, with primary insurance in force growing 2% year-over-year to a record $269 billion [34][35] - The adjusted operating loss for LTC for the full year was $176 million, primarily due to remeasurement losses [33] Market Data and Key Metrics Changes - Enact's PMIER sufficiency ratio remained strong at 167%, approximately $2.1 billion above requirements [35] - Genworth's share of Enact's book value increased to $4.1 billion at year-end 2024, up from $3.8 billion at year-end 2023 [36] Company Strategy and Development Direction - The company aims to create shareholder value through its 81% ownership stake in Enact, which has returned $903 million in capital since its IPO, including $289 million in 2024 [17] - The CareScout Quality Network has expanded to cover 86% of the aged 65-plus population in the U.S., with nearly 500 providers joining the network [11][12] - The company plans to invest $75 million in the new CareScout Insurance Company in 2025 to meet regulatory requirements [26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the progress made in 2024 and the momentum building for future growth, particularly through CareScout and Enact [7][28] - The company anticipates generating $1 billion to $1.5 billion in claims savings over time through the CareScout Quality Network [22] - Management highlighted the importance of maintaining self-sustainability in legacy LTC businesses through the multiyear rate action plan (MYRAP) [18][39] Other Important Information - The company ended Q4 with holding company cash and liquid assets of $294 million, including $186 million set aside for future obligations [16][52] - Genworth repurchased 51 million shares in Q4 at an average price of $7.32 per share, with plans to allocate $100 million to $120 million for share repurchases in 2025 [54][55] Q&A Session Summary Question: Update on CareScout Services revenue expectations - Management indicated that CareScout Services already generates revenue from the assessment business and expects to grow products and customer base in 2025 [60][61] Question: Timing of the U.K. court case - The court case between AXA and Santander is scheduled for early March, with an expected duration of about six weeks if it goes to trial [67][68] Question: Funding for CareScout Insurance entity - The capital contribution for the new CareScout Insurance entity will be funded from existing holding company resources, as part of the base operating plan [69][71]

Genworth Financial (GNW) Q4 2024 Earnings Call February 19, 2025 09:00 AM ET Company Participants Brian Johnson - Head of Investors RelationsThomas McInerney - President and Chief Executive OfficerJerome Upton - Executive VP & CFORyan Krueger - Managing DirectorSamir Shah - President & CEO Operator Good morning, ladies and gentlemen, and welcome to Genworth Financial's Fourth Quarter twenty twenty four Earnings Conference Call. My name is Katie, and I will be your coordinator today. At this time, all partic ...